Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

JAK3 Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients.

Guerrero-Preston R, Lawson F, Rodriguez-Torres S, Noordhuis MG, Pirini F, Manuel L, Valle BL, Hadar T, Rivera B, Folawiyo O, Baez A, Marchionni L, Koch WM, Westra WH, Kim YJ, Eshleman JR, Sidransky D.

Cancer Prev Res (Phila). 2019 Apr;12(4):255-270. doi: 10.1158/1940-6207.CAPR-17-0356. Epub 2019 Feb 18.

PMID:
30777857
2.

Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.

Guerrero-Preston R, Valle BL, Jedlicka A, Turaga N, Folawiyo O, Pirini F, Lawson F, Vergura A, Noordhuis M, Dziedzic A, Pérez G, Renehan M, Guerrero-Diaz C, De Jesus Rodríguez E, Diaz-Montes T, Rodríguez Orengo J, Méndez K, Romaguera J, Trock BJ, Florea L, Sidransky D.

Cancer Prev Res (Phila). 2016 Dec;9(12):915-924. Epub 2016 Sep 26.

3.

Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.

Valle BL, Omwancha WS, Neau SH, Wigent RJ.

Drug Dev Ind Pharm. 2016 Nov;42(11):1903-16. doi: 10.1080/03639045.2016.1181647. Epub 2016 May 10.

PMID:
27100683
4.

Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.

Kagohara LT, Schussel JL, Subbannayya T, Sahasrabuddhe N, Lebron C, Brait M, Maldonado L, Valle BL, Pirini F, Jahuira M, Lopez J, Letelier P, Brebi-Mieville P, Ili C, Pandey A, Chatterjee A, Sidransky D, Guerrero-Preston R.

Future Oncol. 2015;11(2):233-49. doi: 10.2217/fon.14.165. Epub 2014 Jul 28.

5.

Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.

Guerrero-Preston R, Ogawa T, Uemura M, Shumulinsky G, Valle BL, Pirini F, Ravi R, Sidransky D, Keidar M, Trink B.

Int J Mol Med. 2014 Oct;34(4):941-6. doi: 10.3892/ijmm.2014.1849. Epub 2014 Jul 11.

6.

A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.

Sherman-Baust CA, Kuhn E, Valle BL, Shih IeM, Kurman RJ, Wang TL, Amano T, Ko MS, Miyoshi I, Araki Y, Lehrmann E, Zhang Y, Becker KG, Morin PJ.

J Pathol. 2014 Jul;233(3):228-37. doi: 10.1002/path.4353.

7.

Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.

Valle BL, D'Souza T, Becker KG, Wood WH 3rd, Zhang Y, Wersto RP, Morin PJ.

PLoS One. 2013 Apr 24;8(4):e61836. doi: 10.1371/journal.pone.0061836. Print 2013.

8.

Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.

Omwancha WS, Mallipeddi R, Valle BL, Neau SH.

Int J Pharm. 2013 Jan 30;441(1-2):343-51. doi: 10.1016/j.ijpharm.2012.11.022. Epub 2012 Nov 28.

9.

Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.

Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM.

Exp Cell Res. 2008 Oct 1;314(16):2907-18. doi: 10.1016/j.yexcr.2008.07.013. Epub 2008 Jul 25.

PMID:
18687326

Supplemental Content

Loading ...
Support Center